AR surgical procedure steerage co Augmedics raises $36m

Israeli augmented actuality surgical procedure steerage system developer Augmedics has introduced that it has raised $36 million in an over-subscribed Collection C financing spherical led by Almeda Ventures (TASE: AMDA), H.I.G. Capital and Revival Ventures and with the participation of HCA Healthcare Well being Perception Capital and XR Make investments. This newest financing spherical is just eight months after the corporate closed a $21 million Collection B financing, and brings the whole funding up to now to $63 million. This financing spherical included additionally

Israeli surgical visualization co Augmedics raises $8.3m

In December 2019, Augmedics introduced US Meals and Drug Administration (FDA) 510(ok) clearance and the launch of its xvision Backbone System (XVS) within the US. xvision is the primary and solely FDA-approved augmented actuality surgical picture steerage system. The xvision Backbone System permits surgeons to visualise the 3D spinal anatomy of a affected person throughout surgical procedure as if they’d “x-ray imaginative and prescient,” and to precisely navigate devices and implants whereas trying immediately on the affected person, reasonably than a distant display screen. The system is designed to revolutionize how surgical procedure is carried out by giving the surgeon higher visualization, management, and accuracy.

Augmedics started gross sales of xvision Backbone within the US within the second half of 2020 and closed the yr with over 250 spinal surgical procedures carried out with the system. The financing spherical will probably be utilized by Augmedics to proceed its commercialization all through the U.S. and into OUS markets, develop the following technology of merchandise, develop to new indications, and acquire CE certification for gross sales in Europe.

“We’re more than happy to have accomplished this massive financing spherical led by H.I.G. Capital, Revival Healthcare Capital, and Almeda Ventures, which can allow us to advertise and develop our operations and meet the robust demand we’re experiencing for our know-how within the U.S. following our business launch final yr,” mentioned Nissan Elimelech, CEO and founding father of Augmedics.

Almeda Ventures is a public restricted partnership investing in healthcare R&D corporations, headed by Tzahi Sultan, Irit Yaniv, and Amir Blatt. Since its institution in 2020 the fund has invested in six corporations.

Printed by Globes, Israel enterprise information – en.globes.co.il – on March 30, 2021

Source link